🚀 go-pugleaf

Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (September 15, 2012) – Revue de presse (15 septembre
2012)


Ovarian Cancer Screenings Are Not Effective, Panel Says
Tests commonly recommended to screen healthy women for ovarian cancer
do more harm than good and should not be performed, a panel of medical
experts said on Monday.
By Denise Grady. In The New York Times
http://www.nytimes.com/2012/09/11/health/research/ovarian-cancer-tests-are-ineffective-medical-panel-says.html

Cancer Study Points to Tighter Pairing of Drugs and Patients
The first large and comprehensive study of the genetics of a common
lung cancer has found that more than half the tumors from that cancer
have mutations that might be treated by new drugs that are already in
the pipeline or that could be easily developed.
By Gina Kolata. In The New York Times
http://www.nytimes.com/2012/09/10/health/research/for-a-lung-cancer-drug-treatment-may-be-within-reach.html

Pancreatic Cancer May Soon Be the Second-Deadliest Cancer
Pancreatic cancer is the fourth leading cause of cancer death in the
United States, but it could move up to the second as early as 2015,
according to a new report from the Pancreatic Cancer Action Network, a
national organization for pancreatic cancer research and advocacy.
By Allison Takeda. In Huffington Post
http://www.huffingtonpost.com/2012/09/12/pancreatic-cancer-deadly-_n_1877380.html

Pregnancy exposures determine risk of breast cancer in multiple
generations of offspring ‎‎
Researchers from Georgetown Lombardi Comprehensive Cancer Center
demonstrate, in animals, that maternal exposure to a high-fat diet or
excess estrogen during pregnancy can increase breast cancer risk in
multiple generations of female offspring — daughters, granddaughters
and even great-granddaughters.
In Science Codex
http://www.sciencecodex.com/pregnancy_exposures_determine_risk_of_breast_cancer_in_multiple_generations_of_offspring-98216

The Trials of Cancer Trials ‎
I spent last week trying to hope for the recurrence of a malignancy, a
tumor of at least 1.5 centimeters (a bit more than half an inch) that
would be visible on a CT scan. Am I crazy? Maybe, yet without such
evidence of cancer’s return, I won’t be eligible for a trial that can
offer me an experimental drug not yet approved by the Food and Drug
Administration but potentially useful at keeping my cancer at bay for
a bit longer.
By Susan Gubar. In The New York Times
http://well.blogs.nytimes.com/2012/09/13/the-trials-of-cancer-trials/

False Promises on Ovarian Cancer
New evidence that women are more likely to be harmed than helped by
screening tests for ovarian cancer is disturbing. The tests do nothing
to prevent healthy women from dying from the usually fatal disease.
Yet they often lead doctors to perform needless surgeries that cause
serious complications in many patients.
In The New York Times
http://www.nytimes.com/2012/09/12/opinion/false-promises-on-ovarian-cancer.html


Cancer: les métastases cérébrales, encore peu connues, enjeu d'un
congrès
Longtemps négligées car considérées comme intervenantà l'ultime stade
du cancer, les métastases cérébrales font l'objet jusqu'à dimanche à
Marseille, d'une conférence internationale pour mieux cerner leur
origine et définir un traitement plus adapté.
Dans RTBF
http://www.rtbf.be/info/societe/detail_cancer-les-metastases-cerebrales-encore-peu-connues-enjeu-d-un-congres?id=7835232

Dépistage du cancer du sein : plus de bénéfice que de risque ‎‎
Les critiques portent sur les surdiagnostics. Une enquête fait un
bilan complet.
Par Martine Perez. Dans Le Figaro
http://sante.lefigaro.fr/actualite/2012/09/12/19026-depistage-cancer-sein-plus-benefice-que-risque

Cancer du col de l’utérus: 50.000 filles seront vaccinées en Côte
d'Ivoire ‎‎
50.000 filles seront vaccinées contre le cancer du col de l’utérus en
Côte d'Ivoire - Le gouvernement ivoirien a adopté mercredi une
communication du ministère de la Santé et de la Lutte contre le sida
relative à la vaccination de 50.000 jeunes filles contre le papilloma
virus humain, cause du cancer du col de l’utérus chez la femme.
Dans Afrique en ligne
http://www.afriquejet.com/cancer-du-col-de-luterus-50000-filles-seront-vaccinees-en-cote-divoire-2012091344968.html

Cannabis : deux fois plus de risques d'avoir un cancer des testicules‎
C’est une nouvelle découverte sur les effets néfastes du cannabis qu’a
révélé une récente étude américaine. Les fumeurs de cannabis réguliers
auraient deux fois plus de risques d’avoir un cancer des testicules.
Dans LaDépêche.fr
http://www.ladepeche.fr/article/2012/09/10/1436306-cannabis-deux-fois-plus-de-risques-d-avoir-un-cancer-des-testicules.html

Découverte d'une nouvelle molécule anticancer‎‎‎‎
Des équipes de l'Institut Curie et du Centre national de la recherche
scientifique ont découvert une nouvelle molécule qui agit sur les
cellules résistantes à la chimiothérapie traditionnelle, et ce, grâce
à un mécanisme encore inconnu.
Dans Canoë
http://fr.canoe.ca/sante/archives/2012/09/20120907-162925.html







Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix-Corman – InTextoResearch – Baelen  (09/2012)